Abstract
Objective: To present a series of brain metastases from endometrial cancer (EC) and describe a comprehensive review of the literature. Methods: We retrospectively reviewed medical records of 1) patients with cerebral dissemination of EC treated at Mayo Clinic from 1984 to 2001 and 2) all patients referred for treatment of primary brain metastases after primary treatment for EC elsewhere. We also reviewed published case reports and case series describing cerebral spread of EC. Results: Among the 1632 patients treated at Mayo, 14 (0.86%) had primary brain dissemination; 4 additional referral cases were identified (total, 18 patients). In 2 cases (11.1%), diagnosis of brain metastases was made at presentation of EC; in the others, median time to development of brain metastasis was 5 (range, 1-57) months. Median survival was 57 (range, 7-118) months in patients with single cerebral metastases and no extracerebral involvement (n = 6); for the remaining 12 patients, median survival was 4 (range, 0-28) months. Among the 6 patients with single brain metastases, complete surgical excision was possible in 5; in that group, the overall survival was 64 (range, 12-118) months. We identified 98 cases of brain metastases of EC in the literature: 58 were primary cerebral metastases. Overall survival after brain dissemination was significantly higher in patients with a single metastasis without other localization and receiving multimodal treatment including surgery and whole-brain radiotherapy. Conclusions: Single primary brain metastases without extracerebral spread seem to have a relatively favorable prognosis. Aggressive multimodal treatment may include surgery and brain radiation.
| Original language | English (US) |
|---|---|
| Journal | Gynecologic Oncology |
| DOIs | |
| State | Accepted/In press - Mar 11 2016 |
Fingerprint
Keywords
- Brain
- Cerebral
- Endometrial neoplasms
- Neoplasm metastases
- Prognosis
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Oncology
Cite this
Primary brain metastases of endometrial cancer : A report of 18 cases and review of the literature. / Uccella, Stefano; Morris, Jonathan M.; Multinu, Francesco; Cliby, William Arthur; Podratz, Karl C.; Gostout, Bobbie S.; Dowdy, Sean Christopher; Ghezzi, Fabio; Makdisi, Peter B.; Keeney, Gary; Link, Michael J.; Mariani, Andrea.
In: Gynecologic Oncology, 11.03.2016.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Primary brain metastases of endometrial cancer
T2 - A report of 18 cases and review of the literature
AU - Uccella, Stefano
AU - Morris, Jonathan M.
AU - Multinu, Francesco
AU - Cliby, William Arthur
AU - Podratz, Karl C.
AU - Gostout, Bobbie S.
AU - Dowdy, Sean Christopher
AU - Ghezzi, Fabio
AU - Makdisi, Peter B.
AU - Keeney, Gary
AU - Link, Michael J.
AU - Mariani, Andrea
PY - 2016/3/11
Y1 - 2016/3/11
N2 - Objective: To present a series of brain metastases from endometrial cancer (EC) and describe a comprehensive review of the literature. Methods: We retrospectively reviewed medical records of 1) patients with cerebral dissemination of EC treated at Mayo Clinic from 1984 to 2001 and 2) all patients referred for treatment of primary brain metastases after primary treatment for EC elsewhere. We also reviewed published case reports and case series describing cerebral spread of EC. Results: Among the 1632 patients treated at Mayo, 14 (0.86%) had primary brain dissemination; 4 additional referral cases were identified (total, 18 patients). In 2 cases (11.1%), diagnosis of brain metastases was made at presentation of EC; in the others, median time to development of brain metastasis was 5 (range, 1-57) months. Median survival was 57 (range, 7-118) months in patients with single cerebral metastases and no extracerebral involvement (n = 6); for the remaining 12 patients, median survival was 4 (range, 0-28) months. Among the 6 patients with single brain metastases, complete surgical excision was possible in 5; in that group, the overall survival was 64 (range, 12-118) months. We identified 98 cases of brain metastases of EC in the literature: 58 were primary cerebral metastases. Overall survival after brain dissemination was significantly higher in patients with a single metastasis without other localization and receiving multimodal treatment including surgery and whole-brain radiotherapy. Conclusions: Single primary brain metastases without extracerebral spread seem to have a relatively favorable prognosis. Aggressive multimodal treatment may include surgery and brain radiation.
AB - Objective: To present a series of brain metastases from endometrial cancer (EC) and describe a comprehensive review of the literature. Methods: We retrospectively reviewed medical records of 1) patients with cerebral dissemination of EC treated at Mayo Clinic from 1984 to 2001 and 2) all patients referred for treatment of primary brain metastases after primary treatment for EC elsewhere. We also reviewed published case reports and case series describing cerebral spread of EC. Results: Among the 1632 patients treated at Mayo, 14 (0.86%) had primary brain dissemination; 4 additional referral cases were identified (total, 18 patients). In 2 cases (11.1%), diagnosis of brain metastases was made at presentation of EC; in the others, median time to development of brain metastasis was 5 (range, 1-57) months. Median survival was 57 (range, 7-118) months in patients with single cerebral metastases and no extracerebral involvement (n = 6); for the remaining 12 patients, median survival was 4 (range, 0-28) months. Among the 6 patients with single brain metastases, complete surgical excision was possible in 5; in that group, the overall survival was 64 (range, 12-118) months. We identified 98 cases of brain metastases of EC in the literature: 58 were primary cerebral metastases. Overall survival after brain dissemination was significantly higher in patients with a single metastasis without other localization and receiving multimodal treatment including surgery and whole-brain radiotherapy. Conclusions: Single primary brain metastases without extracerebral spread seem to have a relatively favorable prognosis. Aggressive multimodal treatment may include surgery and brain radiation.
KW - Brain
KW - Cerebral
KW - Endometrial neoplasms
KW - Neoplasm metastases
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=84964691684&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964691684&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2016.04.013
DO - 10.1016/j.ygyno.2016.04.013
M3 - Article
JO - Gynecologic Oncology
JF - Gynecologic Oncology
SN - 0090-8258
ER -